Abstract. 2-mercapto-1(:3-4-pyridethyl)benzimidazole (MPB) inhibited the development of antiviral activity induced by interferon in chick cells. The MPB effect was reversed by washing the cells. The action of MPB was on a step immediately following interferon binding but before the cellular RNA and protein synthesis that appear to be required for interferon action. The step blocked by MPB possibly involves cellular phospholipid synthesis.
2-mercapto-1-(,3-4-pyridethyl)benzimidazole (MPB) was first described as a reversible inhibitor of cellular RNA and DNA synthesis.' Subsequent studies in this and other laboratories, however, have indicated that in reality MPB reversibly inhibited either the phosphorylation2 or the uptake of nucleosides,3 and had no effect on cellular macromolecule synthesis in short term experiments3 4 (Fig. 1) or on nucleoside kinases in cell free systems." 5 Endogenous production of nucleosides in animal cells apparently provides a sufficient concentration of nucleic acid precursors for cell growth.
During an investigation of the effects of inhibitors of RNA synthesis on antiviral activity induced by interferon, MPB was found to be a potent inhibitor of interferon action. It was later apparent that this effect was not due to an inhibition of cellular RNA synthesis ( Fig. 1 DMSO employed (0.1%) had no effect on interferon action. Partially purified chick interferon (10,000 units/ml; 179 u.g protein/ml) was prepared by the method of Fantes.9
The interferon employed was generously donated by Dr. Fantes, Glaxo Laboratories, Bucks.
Results. Chick cell monolayers were incubated with 100 units of interferon in the presence or absence of 50 jig/ml of MPB. After four hours the cells were washed and infected with vesicular stomatitis virus. Incubation of interferon with MPB caused almost complete inhibition of interferon action ( Table 1) . MPB had no severe toxic effect on the cells since virus growth was not inhibited in cells previously incubated with the drug. In all subsequent studies a series of incubation mixtures similar to those listed in Table 1 was included to act as a positive control for MPB action.
In an experiment with a series of MPB concentrations decreasing antiviral activity due to interferon action was seen with increasing MPB dose levels ( Fig. 1 ). In the same experiment the effects on cellular RNA and protein synthesis of the concentrations of MPB employed were studied. No significant inhibitory effect by any of the concentrations of MPB used was noted (Fig. 1 inhibition of RNA synthesis by MPB when (32P)P04 incorporation into RNA was studied. They also showed that MPB has no effect on the species of RNA produced. 3 The inhibitory effect of MPB could have been due to direct inactivation of interferon. Therefore, 10,000 units/ml of interferon was incubated at 370 for four hours in the presence of 50 Ag/ml of MPB. The mixture was then diluted 100-fold and tested for antiviral activity. No direct inactivation of interferon by MPB was found (Table 2 ). In order to eliminate a possible stoichiometric inactivation of interferon by MPB the following experiment was also performed.
A solution containing MPB (50 gg/ml) and interferon (100 units/ml) was incubated at 370 for four hours. The solution was then dialyzed for two hours at 40. diluted tenfold and tested for antiviral activity. As also shown in Table  2 no direct inactivation of interferon took place under these conditions. Therefore, MPB appeared to be blocking some phase of the cell-interferon interaction.
Studies were undertaken to find an intracellular site of MPB effect on interferon action. It had already been shown (Fig. 1) that MPB had no effect on cellular RNA or protein synthesis which are thought to be required for interferon action. 10 The inhibition of nucleoside uptake by MPB was reversed by washing.1-3 In order to determine whether the inhibition of interferon action by MPB was also reversed by washing, monolayers were incubated with MPB for four hours, washed, and then treated with interferon. Under these conditions MPB treatment did not inhibit interferon action (Table 3 ). This effect of MPB was, therefore, also reversible. The effect of MPB on already established antiviral activity induced by interferon was tested. Monolayers were treated with interferon for 4 hours and then with MPB for an additional 4 hours. MPB treatment under these conditions also had no effect on interferon action (Table 4) . Therefore, MPB treatment did not reverse the antiviral state already established by interferon. The results discussed so far indicated that MPB does not inhibit cellular RNA or protein synthesis or directly inactivate interferon or inhibit antiviral activity established by interferon. Since these findings had eliminated as sites of MPB action the known intracellular steps necessary to establish the antiviral state in interferon treated cells, studies on interferon binding were undertaken. Interferon has been shown to bind rapidly and firmly to a superficial cell site.'" This binding was necessary for development of antiviral activity. The binding reaction was not temperature sensitive since it took place at 10 but subsequent incubation at 370 for several hours after binding at 10 was required for antiviral activity to develop. Treatment of cells with actinomycin D at 370 after interferon binding at 10 inhibited the development of antiviral activity. Incubation at 10 therefore distinguished the binding reaction from some of the subsequent steps necessary for interferon action. Only binding to a superficial site on the cell seemed to take place in a 10-minute incubation at 10 because interferon bound under these conditions could still be destroyed by trypsin treatment.
To test the effect of MPB on interferon binding, chick cells were incubated with MPB at 370 for one hour and then were incubated at 1°for an additional hour in the presence of 1000 units/ml of interferon with or without MPB. The cells were then washed and incubated for four hours at 37°. Under these conditions MPB had no effect on interferon action (Table a) . This result indicates that MPB does not inhibit interferon binding. The following study was performed, therefore, in order to determine whether MPB treatment had an effect on a step after the binding reaction in the induction of antiviral activity by interferon treatment. Cells were incubated with interferon at 10 for ten minutes or for one hour. They were then washed with cold medium, MPB was added, and the cells were warmed to 370 and incubated for an additional four hours. Under these conditions MPB treatment had no effect on interferon action if the incubation at 10 was allowed to proceed for one hour; however, interferon action was blocked by MPB addition after a 10-minute incubation at 10 (Table 6 ). This result clearly indicated that a reaction which follows interferon binding and which takes place at 10 was the step which was blocked when the development of antiviral activity was inhibited by MPB. Evidence for the existence of such a step in the induction of antiviral activity by interferon has not been previously reported although somewhat similar findings have been reported in an investigation on the mechanism of action of polypeptide hormones. The action of thyroid stimulating hormone (TSH) previously bound to thyroid cells was inhibited by incubation with anti-TSH antiserum if the binding reaction had been allowed to proceed in the cold for only five minutes; however, little effect of the antiserum was seen following a one-hour incubation. 12 Because the step which is blocked by MPB would appear to be membrane associated, the effect of MPB treatment on cell phospholipid synthesis was also studied. Chick cells were incubated with 50 Ag/ml of MPB at 370 for one hour and 30 yCi/ml of H3 32PO4 was added for two additional hours. A marked inhibition of phospholipid synthesis was observed in the MPB treated cells (Table 7) . Therefore, the step blocked by MPB may involve cellular phos- While it is not necessarily true that MPB blocks all of these reactions by the same mechanism, the study of the inhibition of interferon action may help to provide a general explanation for MPB's varied effects since it is likely that all involve membrane associated reactions at some stage. As a result of its inhibition of phospholipid synthesis, MPB may cause a rapid alteration in membrane properties which is readily reversed by washing the cells free of MPB.
